MovDisordV3, PubMed, Corpus, bibRecord, 000964

Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.

Identifieur interne : 000964 ( PubMed/Corpus ); précédent : 000963; suivant : 000965

Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.

Auteurs : Virginie Lambrecq ; Florence Riant ; Elisabeth Tournier-Lasserve ; Véronique Michel ; Pierre Burbaud

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.

RBID : pubmed:23536488

English descriptors

KwdEn :
- Caffeine (therapeutic use), Chorea (drug therapy), Chorea (genetics), Female, Humans, Membrane Proteins (genetics), Mutation (genetics), Nerve Tissue Proteins (genetics), Phosphodiesterase Inhibitors (therapeutic use), Young Adult.
MESH :
- chemical , genetics : Membrane Proteins, Nerve Tissue Proteins.
- chemical , therapeutic use : Caffeine, Phosphodiesterase Inhibitors.
- drug therapy : Chorea.
- genetics : Chorea, Mutation.
- Female, Humans, Young Adult.

DOI: 10.1002/mds.25450
PubMed: 23536488

Links to Exploration step

pubmed:23536488

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.</title>
<author><name sortKey="Lambrecq, Virginie" sort="Lambrecq, Virginie" uniqKey="Lambrecq V" first="Virginie" last="Lambrecq">Virginie Lambrecq</name>
</author>
<author><name sortKey="Riant, Florence" sort="Riant, Florence" uniqKey="Riant F" first="Florence" last="Riant">Florence Riant</name>
</author>
<author><name sortKey="Tournier Lasserve, Elisabeth" sort="Tournier Lasserve, Elisabeth" uniqKey="Tournier Lasserve E" first="Elisabeth" last="Tournier-Lasserve">Elisabeth Tournier-Lasserve</name>
</author>
<author><name sortKey="Michel, Veronique" sort="Michel, Veronique" uniqKey="Michel V" first="Véronique" last="Michel">Véronique Michel</name>
</author>
<author><name sortKey="Burbaud, Pierre" sort="Burbaud, Pierre" uniqKey="Burbaud P" first="Pierre" last="Burbaud">Pierre Burbaud</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="doi">10.1002/mds.25450</idno>
<idno type="RBID">pubmed:23536488</idno>
<idno type="pmid">23536488</idno>
<idno type="wicri:Area/PubMed/Corpus">000964</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.</title>
<author><name sortKey="Lambrecq, Virginie" sort="Lambrecq, Virginie" uniqKey="Lambrecq V" first="Virginie" last="Lambrecq">Virginie Lambrecq</name>
</author>
<author><name sortKey="Riant, Florence" sort="Riant, Florence" uniqKey="Riant F" first="Florence" last="Riant">Florence Riant</name>
</author>
<author><name sortKey="Tournier Lasserve, Elisabeth" sort="Tournier Lasserve, Elisabeth" uniqKey="Tournier Lasserve E" first="Elisabeth" last="Tournier-Lasserve">Elisabeth Tournier-Lasserve</name>
</author>
<author><name sortKey="Michel, Veronique" sort="Michel, Veronique" uniqKey="Michel V" first="Véronique" last="Michel">Véronique Michel</name>
</author>
<author><name sortKey="Burbaud, Pierre" sort="Burbaud, Pierre" uniqKey="Burbaud P" first="Pierre" last="Burbaud">Pierre Burbaud</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Caffeine (therapeutic use)</term>
<term>Chorea (drug therapy)</term>
<term>Chorea (genetics)</term>
<term>Female</term>
<term>Humans</term>
<term>Membrane Proteins (genetics)</term>
<term>Mutation (genetics)</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Phosphodiesterase Inhibitors (therapeutic use)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Proteins</term>
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Caffeine</term>
<term>Phosphodiesterase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Chorea</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Chorea</term>
<term>Mutation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23536488</PMID>
<DateCreated><Year>2013</Year>
<Month>05</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>01</Month>
<Day>02</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>28</Volume>
<Issue>5</Issue>
<PubDate><Year>2013</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.</ArticleTitle>
<Pagination><MedlinePgn>683</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25450</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lambrecq</LastName>
<ForeName>Virginie</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Riant</LastName>
<ForeName>Florence</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tournier-Lasserve</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Michel</LastName>
<ForeName>Véronique</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Burbaud</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>03</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C569370">PRRT2 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010726">Phosphodiesterase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3G6A5W338E</RegistryNumber>
<NameOfSubstance UI="D002110">Caffeine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D002110">Caffeine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002819">Chorea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009419">Nerve Tissue Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010726">Phosphodiesterase Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>7</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>1</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>2</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year>
<Month>3</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>1</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.25450</ArticleId>
<ArticleId IdType="pubmed">23536488</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000964 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000964 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23536488
   |texte=   Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:23536488" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.

Caffeine improved paroxysmal dyskinesia caused by the PRRT2 mutation.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki